השוואת שיטות
סקרו את השיטות שבחרתם זו לצד זו; שורות שבהן יש הבדל מודגשות.
| ניתוח RNA-seq דיפרנציאלי ברמת התא הבודד× | ניתוח ביטוי דיפרנציאלי ב-RNA-seq× | |
|---|---|---|
| תחום | ביואינפורמטיקה | ביואינפורמטיקה |
| משפחה | Process / pipeline | Process / pipeline |
| שנת המקור≠ | 2015–2021 | 2008–2010 (RNA-seq DE methodology established) |
| הוגה השיטה≠ | Multiple contributors; pseudobulk framework formalized by Squair et al. (2021); Seurat/FindMarkers by Satija lab (~2015) | Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010) |
| סוג≠ | Computational bioinformatics pipeline | Quantitative genomics pipeline |
| מקור מכונן≠ | Hafemeister, C., & Satija, R. (2019). Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biology, 20, 296. link ↗ | Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. DOI ↗ |
| כינויים | scRNA-seq differential analysis, single-cell differential expression analysis, scDE analysis, single-cell comparative transcriptomics | RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA |
| קשורות≠ | 3 | 6 |
| תקציר≠ | Differential single-cell RNA-seq (scRNA-seq) analysis is a computational pipeline that compares transcriptomic profiles across biological conditions — such as treated versus untreated, disease versus healthy, or time points — at single-cell resolution. It identifies which genes, cell types, and cell states change between conditions, providing mechanistic insight that bulk RNA-seq comparisons cannot offer. The approach combines clustering, cell-type annotation, and statistical testing, typically using pseudobulk aggregation to account for within-sample correlation. | RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values. |
| ScholarGateמערך נתונים ↗ |
|
|